# The effects of iTBS to cerebellar vermis on balance function in frail older people: A protocol for a randomized controlled trial

**Authors:** Zuoyan Liu, Neng Huang, Kehong Zhao, Na Long, Ruibao Fu, Xiuying Hu

PMC · DOI: 10.1371/journal.pone.0339030 · PLOS One · 2026-01-22

## TL;DR

This study will test if a brain stimulation technique improves balance in frail older people.

## Contribution

This is the first randomized controlled trial to evaluate intermittent theta burst stimulation on cerebellar vermis for balance in frail older adults.

## Key findings

- The trial will assess balance function as the primary outcome.
- Secondary outcomes include frailty, walking ability, and sensory organization.
- Results may provide evidence-based rehabilitation strategies for therapists.

## Abstract

With the gradual deepening of the aging of the population, the closely related problem of frailty in older people is becoming increasingly prominent. Frailty can increase the risk of bodily damage and adverse health outcomes such as falls, disabilities, hospitalizations, institutionalization, and death. Intermittent theta burst stimulation is a special stimulation mode of repetitive transcranial magnetic stimulation, which can enhance synaptic transmission by mimicking cortical theta rhythms. Some previous studies have suggested that intermittent theta burst stimulation is effective in improving balance function and motor function. However, few studies have explored the effects of intermittent theta burst stimulation to cerebellar vermis on balance function in frail older people.

To introduce a randomized controlled trial protocol, which will be used to evaluate the efficacy of intermittent theta burst stimulation to cerebellar vermis on balance function in frail older people.

This trial is a double-blind, two-arm randomized controlled trial. Frail older people with balance dysfunction will be recruited. All participants will be randomly assigned to experimental group who will receive intermittent theta burst stimulation to cerebellar vermis and control group who will receive false stimulation in a 1:1 ratio. All participants will also receive motor training once a day for 30–60 minutes each time, for a total of 20 sessions. The primary outcome will be balance function and the secondary outcomes will include frailty, walking ability, sensory organisation test, limits of stability, and rhythmic weight shift. All outcomes will be collected at baseline and in the week immediately post-intervention.

This study will be the first randomized controlled trial on the effects of iTBS to cerebellar vermis on balance function in frail older people. It is expected that this study, if proven effective in improving the balance function in frail older people, will provide evidence-based rehabilitation strategies for rehabilitation therapist.

Screening of participants will begin in September 2025.

## Full-text entities

- **Genes:** BDNF (brain derived neurotrophic factor) [NCBI Gene 627] {aka ANON2, BULN2}
- **Diseases:** cerebellar vermis lesions (MESH:C537206), seizures (MESH:D012640), motor dysfunction (MESH:D000068079), Frail (MESH:D000073496), brain atrophy (MESH:C566985), muscle (MESH:D019042), decreased muscle strength (MESH:D009123), paraplegia (MESH:D010264), hemiplegia (MESH:D006429), stroke (MESH:D020521), lower limb fracture (MESH:D038061), brain dysfunction (MESH:D001927), nerve injury (MESH:D000080902), cognitive decline (MESH:D003072), death (MESH:D003643), loss of independence (MESH:D064129), Parkinson's disease (MESH:D010300), amputation (MESH:C565682), heart, lung, circulation and metabolism diseases (MESH:D008171), balance dysfunction (MESH:D006331), falls (MESH:C537863), multiple system atrophy (MESH:D019578), balance problems (MESH:D019973), spinal fracture (MESH:D016103), decline in muscle strength (MESH:D009135), sensory dysfunction (MESH:D012678)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12826461/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12826461/full.md

## References

46 references — full list in the complete paper: https://tomesphere.com/paper/PMC12826461/full.md

---
Source: https://tomesphere.com/paper/PMC12826461